IMMX
Price
$2.04
Change
-$0.01 (-0.49%)
Updated
Sep 25 closing price
Capitalization
66.64M
68 days until earnings call
MSCLF
Price
$0.48
Change
-$0.02 (-4.00%)
Updated
Sep 24 closing price
Capitalization
85.35M
Interact to see
Advertisement

IMMX vs MSCLF

Header iconIMMX vs MSCLF Comparison
Open Charts IMMX vs MSCLFBanner chart's image
Immix Biopharma
Price$2.04
Change-$0.01 (-0.49%)
Volume$134.7K
Capitalization66.64M
SATELLOS BIOSCIENCE
Price$0.48
Change-$0.02 (-4.00%)
Volume$14.65K
Capitalization85.35M
IMMX vs MSCLF Comparison Chart in %
Loading...
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMX vs. MSCLF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Buy and MSCLF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (IMMX: $2.04 vs. MSCLF: $0.48)
Brand notoriety: IMMX and MSCLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 62% vs. MSCLF: 35%
Market capitalization -- IMMX: $66.64M vs. MSCLF: $85.35M
IMMX [@Biotechnology] is valued at $66.64M. MSCLF’s [@Biotechnology] market capitalization is $85.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileMSCLF’s FA Score has 1 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • MSCLF’s FA Score: 1 green, 4 red.
According to our system of comparison, MSCLF is a better buy in the long-term than IMMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 5 TA indicator(s) are bullish while MSCLF’s TA Score has 5 bullish TA indicator(s).

  • IMMX’s TA Score: 5 bullish, 3 bearish.
  • MSCLF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IMMX is a better buy in the short-term than MSCLF.

Price Growth

IMMX (@Biotechnology) experienced а -2.39% price change this week, while MSCLF (@Biotechnology) price change was +6.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

IMMX is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MSCLF($85.3M) has a higher market cap than IMMX($66.6M). IMMX YTD gains are higher at: -7.273 vs. MSCLF (-18.186). MSCLF has higher annual earnings (EBITDA): -21.39M vs. IMMX (-23.58M). MSCLF has more cash in the bank: 38.2M vs. IMMX (11.6M). IMMX (0) and MSCLF (0) have equivalent revenues.
IMMXMSCLFIMMX / MSCLF
Capitalization66.6M85.3M78%
EBITDA-23.58M-21.39M110%
Gain YTD-7.273-18.18640%
P/E RatioN/A2.62-
Revenue00-
Total Cash11.6M38.2M30%
Total Debt1.04MN/A-
FUNDAMENTALS RATINGS
MSCLF: Fundamental Ratings
MSCLF
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMMXMSCLF
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 23 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IMMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSASF0.29N/A
+1.52%
RESAAS Services, Inc.
TCHBF200.00N/A
N/A
Tecan AG
FAXRF13.50N/A
N/A
Fairfax Financial Holdings Ltd.
CRHKF3.48N/A
N/A
China Resources Beer Holdings Company Limited
SMOPF1.85N/A
N/A
SMARTOPTICS GROUP AS

IMMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMX has been loosely correlated with IMTX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMX jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
-0.49%
IMTX - IMMX
35%
Loosely correlated
-3.82%
CRNX - IMMX
32%
Poorly correlated
+2.02%
ERAS - IMMX
30%
Poorly correlated
-5.24%
FOLD - IMMX
30%
Poorly correlated
-0.36%
ATXS - IMMX
30%
Poorly correlated
-1.65%
More

MSCLF and

Correlation & Price change

A.I.dvisor tells us that MSCLF and AKBLF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MSCLF and AKBLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSCLF
1D Price
Change %
MSCLF100%
N/A
AKBLF - MSCLF
27%
Poorly correlated
N/A
CDIO - MSCLF
20%
Poorly correlated
-4.92%
IMMX - MSCLF
12%
Poorly correlated
-0.49%
NRSN - MSCLF
11%
Poorly correlated
-4.84%
NEUP - MSCLF
8%
Poorly correlated
+8.73%
More